
LAVA Therapeutics NV
NASDAQ:LVTX

Income Statement
Earnings Waterfall
LAVA Therapeutics NV
Revenue
|
7.3m
USD
|
Cost of Revenue
|
-154k
USD
|
Gross Profit
|
7.2m
USD
|
Operating Expenses
|
-35.2m
USD
|
Operating Income
|
-28m
USD
|
Other Expenses
|
397k
USD
|
Net Income
|
-27.6m
USD
|
Income Statement
LAVA Therapeutics NV
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||
Revenue |
6
N/A
|
8
+37%
|
5
-36%
|
9
+84%
|
9
-7%
|
22
+153%
|
19
-11%
|
20
+1%
|
24
+24%
|
9
-63%
|
7
-25%
|
13
+85%
|
7
-41%
|
7
-1%
|
|
Gross Profit | |||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(0)
|
(0)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
+948%
|
3
+1%
|
3
+7%
|
10
+204%
|
7
-28%
|
7
-1%
|
|
Operating Income | |||||||||||||||
Operating Expenses |
(47)
|
(57)
|
(49)
|
(79)
|
(83)
|
(89)
|
(54)
|
(56)
|
(61)
|
(55)
|
(47)
|
(42)
|
(35)
|
(35)
|
|
Selling, General & Administrative |
(7)
|
(10)
|
(12)
|
(22)
|
(23)
|
(23)
|
(14)
|
(14)
|
(14)
|
(14)
|
(13)
|
(12)
|
(11)
|
(11)
|
|
Research & Development |
(40)
|
(47)
|
(37)
|
(57)
|
(60)
|
(67)
|
(40)
|
(42)
|
(47)
|
(41)
|
(34)
|
(30)
|
(24)
|
(24)
|
|
Operating Income |
(41)
N/A
|
(49)
-21%
|
(44)
+10%
|
(70)
-58%
|
(75)
-6%
|
(68)
+9%
|
(35)
+48%
|
(38)
-8%
|
(40)
-7%
|
(49)
-23%
|
(43)
+12%
|
(32)
+27%
|
(27)
+13%
|
(28)
-2%
|
|
Pre-Tax Income | |||||||||||||||
Interest Income Expense |
0
|
0
|
(1)
|
1
|
4
|
7
|
3
|
2
|
(0)
|
(1)
|
2
|
3
|
4
|
1
|
|
Total Other Income |
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(42)
N/A
|
(51)
-21%
|
(45)
+12%
|
(71)
-56%
|
(72)
-2%
|
(62)
+14%
|
(32)
+49%
|
(36)
-13%
|
(40)
-13%
|
(50)
-24%
|
(42)
+17%
|
(28)
+32%
|
(24)
+16%
|
(27)
-14%
|
|
Net Income | |||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(42)
|
(51)
|
(45)
|
(71)
|
(72)
|
(62)
|
(32)
|
(36)
|
(41)
|
(50)
|
(42)
|
(29)
|
(24)
|
(28)
|
|
Net Income (Common) |
(42)
N/A
|
(51)
-21%
|
(45)
+11%
|
(71)
-56%
|
(72)
-2%
|
(62)
+14%
|
(32)
+49%
|
(36)
-13%
|
(41)
-13%
|
(50)
-24%
|
(42)
+17%
|
(29)
+32%
|
(24)
+15%
|
(28)
-14%
|
|
EPS (Diluted) |
-1.67
N/A
|
-2.02
-21%
|
-2.3
-14%
|
-2.75
-20%
|
-2.79
-1%
|
-2.35
+16%
|
-1.23
+48%
|
-1.37
-11%
|
-1.54
-12%
|
-1.92
-25%
|
-1.57
+18%
|
-1.07
+32%
|
-0.9
+16%
|
-1.02
-13%
|